Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2024)

Eton Pharmaceuticals has disclosed Non Operating Income across 6 years of filings, most recently posting -$1.1 million for Q4 2024.

• In Q4 2024, Non Operating Income fell 7025.0% year-over-year to -$1.1 million; the TTM figure through Dec 2024 stood at -$1.2 million (down 340.76% YoY), while the FY2025 annual figure was -$3.7 million, down 206.69% from the prior year.
• Non Operating Income came in at -$1.1 million for Q4 2024 at Eton Pharmaceuticals, down from -$8000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $676000.0 in Q2 2023 to a low of -$1.1 million in Q4 2024.
• Average Non Operating Income over 5 years is -$149900.0, with a median of -$171000.0 recorded in 2020.
• Year-over-year, Non Operating Income soared 410.09% in 2023 and slumped 7025.0% in 2024.
• Over 5 years, Non Operating Income stood at -$267000.0 in 2020, then declined by 3.0% to -$275000.0 in 2021, then surged by 45.45% to -$150000.0 in 2022, then soared by 89.33% to -$16000.0 in 2023, then tumbled by 7025.0% to -$1.1 million in 2024.
• Per Business Quant data, the three most recent Non Operating Income figures were -$1.1 million in Q4 2024, -$8000.0 in Q3 2024, and -$52000.0 in Q2 2024.